1-7 of 7
Authors: Jun Zhang
Save search
Sort by
Journal Article

Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy

PDF
Xingyuan Cheng and others
The Oncologist, Volume 28, Issue 8, August 2023, Pages e606–e616, https://doi.org/10.1093/oncolo/oyad094
Published: 15 April 2023
Journal Article

Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib

PDF
Jun Zhang and others
The Oncologist, Volume 28, Issue 4, April 2023, Pages 287–296, https://doi.org/10.1093/oncolo/oyad051
Published: 09 March 2023
Journal Article

Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro Study

PDF
Yongjian Zhou and others
The Oncologist, Volume 28, Issue 4, April 2023, Pages e191–e197, https://doi.org/10.1093/oncolo/oyac271
Published: 13 February 2023
Journal Article

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study

PDF
Jian Li and others
The Oncologist, Volume 28, Issue 2, February 2023, Pages 187–e114, https://doi.org/10.1093/oncolo/oyac242
Published: 07 December 2022
Journal Article

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study

PDF
Robert Wesolowski and others
The Oncologist, Volume 25, Issue 8, August 2020, Pages e1158–e1169, https://doi.org/10.1634/theoncologist.2020-0039
Published: 17 June 2020
Journal Article

Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors

PDF
Ralf-Dieter Hofheinz and others
The Oncologist, Volume 21, Issue 12, December 2016, Pages 1483–1491, https://doi.org/10.1634/theoncologist.2016-0051
Published: 22 July 2016
Journal Article

The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma

PDF
Jifang Gong and others
The Oncologist, Volume 19, Issue 2, February 2014, Pages 173–174, https://doi.org/10.1634/theoncologist.2013-0137
Published: 23 January 2014